News search

    E.g., 20/04/2025
    E.g., 20/04/2025
    Jesús Vázquez, Jacob Fog Bentzon, Emilio Camafeita y Esmeralda Lewis.
    About the CNIC
    13 Apr 2021
    JACC: CNIC researchers explain how high blood pressure, the most important cause of disease worldwide, accelerates atherosclerosis

    The new insight supports the need to keep both LDL cholesterol and blood pressure low throughout life by healthy diet choices, weight control, exercise, and, when needed, by drug therapy
    Mª Ángeles Zuriaga, Mirian Díez, Fátima Sánchez-Cabo, Ana Dopazo, José Javier Fuster, Ana Quintas y Jorge de la Barrera.
    Research
    5 Apr 2021
    JACC: CNIC scientists identify mutations acquired by blood cells that accelerate heart failure progression

    The study, carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and the Hospital Universitario Virgen de Arrixaca in Murcia, establishes clonal hematopoiesis as a new cardiovascular risk factor and an important link between aging and cardiovascular disease
    Marta Amorós Pérez, Virginia Zorita, Nuria Matesanz, Marian Zuriaga y José Javier Fuster.
    About the CNIC
    23 Dec 2020
    CNIC to coordinate a European project investigating how cancer therapies promote atherosclerosis and cardiovascular disease

    The project will investigate the role of clonal hematopoiesis—the formation of mutated hematopoietic stem-cell clones promoted by anti-cancer therapies—in the development of atherosclerosis and associated cardiovascular disease
    Irene Fernández-Nueda, Carlos Cerón y Marta Cortés-Canteli
    About the CNIC
    15 Dec 2020
    CNIC scientists coordinate a European project to develop a biomarker for the early identification of the vascular component in Alzheimer disease

    The BioClotAD project, coordinated by CNIC scientist Dr Marta Cortés Canteli, has been selected by the EU Joint Programme – Neurodegenerative Disease Research (JPND)
    Jesús Vázquez, Almudena Ramiro, José Luis Martín Ventura, Inmaculada Martos Folgado, Cristina Lorenzo y Sonia Mur.
    Research
    2 Dec 2020
    Nature: CNIC scientists identify a new diagnostic and therapeutic target for cardiovascular disease

    Un estudio que se publica en Nature muestra a la proteína mitocondrial ALDH4A1 como un nuevo autoantígeno implicado en los procesos de la aterosclerosis
    Research
    16 Oct 2020
    Nature Reviews Endocrinology: Protein kinases could be the next target in the treatment of diseases associated with obesity

    Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) review the roles of a groups of proteins called stress kinases in metabolism in an article published in Nature Reviews Endocrinology
    Research
    17 Sep 2020
    Nature Metabolism: CNIC researchers discover a mechanism allowing immune cells to regulate obesity

    The results published in Nature Metabolism could be useful to design new treatments for the obese and overweight, and for some associated pathologies, including fatty liver disease and type 2 diabetes
    Imágenes de las coroides de ratones control (izquierda) y tras la eliminación de IHH de las células endoteliales (derecha), lo que resulta en una disminución del número de mastocitos (puntos blancos).
    Research
    20 Mar 2020
    Journal of Experimental Medicine:CNIC scientists identify an immunological regulatory circuit that may play a central role in ocular diseases

    Scientists at the CNIC and Weill Cornell Medicine have identified an inflammatory regulatory circuit controlled by a subtype of endothelial cells in the eye
    Dr. Filip Swirski
    About the CNIC
    28 Feb 2020
    "Sleep has been proven to be a risk factor for cardiovascular disease”

    Dr. Filip Swirski is associate professor at Harvard Medical School and Massachusetts General Hospital (USA) and one of the leading experts on the relationship between sleep and heart disease
    María Ángeles Moro
    About the CNIC
    11 Feb 2020
    "Various diseases and all very mechanistically different, are included under the name of vascular dementia, or better called, cognitive vascular deterioration"

    María Ángeles Moro leads the CNIC's Neurovascular Pathophysiology Laboratory.